ACAD
38.21
+0.07
+0.18%
AEMD
0.21
+0.02
+10.34%
APRI
2.46
+0.07
+3.05%
ARNA
4.29
+0.25
+6.06%
ATEC
1.5
-0.02
-1.32%
CFN
60.27
+0.14
+0.23%
CNAT
6.28
-0.04
-0.63%
CRXM
0.2
+0.01
+5.83%
CYTX
1.13
-0.07
-5.83%
DXCM
60.04
+0.99
+1.68%
GNMK
12.68
-0.1
-0.78%
HALO
15.67
+0.44
+2.89%
ILMN
192.71
-3.32
-1.69%
INNV
0.17
-0.02
-10.81%
INO
7.37
+0.32
+4.54%
ISCO
0.06
+0.00
+1.72%
ISIS
70.27
+1.61
+2.35%
LGND
67.52
+1.07
+1.61%
LPTN
2.93
-0.02
-0.68%
MBVX
1
+0.07
+7.53%
MEIP
5.5
-0.24
-4.18%
MNOV
3.61
-0.03
-0.69%
MRTX
24.34
+0.79
+3.35%
MSTX
0.56
+0.04
+7.43%
NBIX
41.42
+0.56
+1.37%
NUVA
45.03
+0.77
+1.74%
ONCS
0.38
+0.01
+1.34%
ONVO
5.84
+0.04
+0.69%
OREX
8.62
+0.98
+12.83%
OTIC
36.74
-0.13
-0.35%
QDEL
26
+0.19
+0.74%
RCPT
128.07
+3.08
+2.46%
RGLS
18.48
+0.19
+1.04%
RMD
64.92
+0.43
+0.67%
SCIE
0.03
+0.01
+17.17%
SPHS
0.8
+0.09
+13.07%
SRNE
13.58
+0.38
+2.88%
TROV
6.35
-0.01
-0.16%
VICL
1.01
+0.02
+1.81%
VOLC
17.99
0.00
0.00%
ZGNX
1.69
+0.02
+1.20%
Home » Archive by Category

Xconomy

Biotech Unveils Drug for Viral Infections Tied to Cervical Cancer

August 22, 2014 – 4:00 am

A small San Diego biotech has identified a drug that appears to prevent several subtypes of the human papillomavirus (HPV) from replicating—including the two HPV subtypes that cause 70 percent…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More

August 21, 2014 – 11:09 am

Big news this morning: two Americans treated with an experimental Ebola treatment have recovered and are now out of the hospital. (A third person, a Spaniard, who received the treatment unfortunately…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Ebola, Mapp, Tekmira, ViaCyte & More

August 21, 2014 – 11:09 am

Big news this morning: two Americans treated with an experimental Ebola treatment have recovered and are now out of the hospital. (A third person, a Spaniard, who received the treatment unfortunately…

[[Click headline to continue reading.]]

Sanford-Burnham Seeks Improved Pharma Ties with New CEO from GSK

August 19, 2014 – 5:02 pm

Following an executive search that took about 18 months, San Diego’s Sanford-Burnham Medical Research Institute named a new CEO today. He is Perry Nisen, a pediatric cancer specialist who specialized…

[[Click headline to continue reading.]]

Sanford-Burnham Seeks Improved Pharma Ties with New CEO from GSK

August 19, 2014 – 5:02 pm

Following an executive search that took about 18 months, San Diego’s Sanford-Burnham Medical Research Institute named a new CEO today. He is Perry Nisen, a pediatric cancer specialist who specialized…

[[Click headline to continue reading.]]

HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

August 19, 2014 – 3:00 am

HealthQuest Capital, founded last year by Sofinnova Ventures partner Garheng Kong, says it has raised $110 million for its debut fund and already has invested in several medical technology and…

[[Click headline to continue reading.]]

HealthQuest Capital Raises $110M for Debut Fund with Medtech Focus

August 19, 2014 – 3:00 am

HealthQuest Capital, founded last year by Sofinnova Ventures partner Garheng Kong, says it has raised $110 million for its debut fund and already has invested in several medical technology and…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More

August 14, 2014 – 11:35 am

[Corrected 8/14/14, 8:11pm. See below.] When Amgen (NASDAQ: AMGN) bought South San Francisco-based Onyx Pharmaceuticals last year for $10.4 billion, it expected great things from Onyx’s…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More

August 14, 2014 – 11:35 am

[Corrected 8/14/14, 8:11pm. See below.] When Amgen (NASDAQ: AMGN) bought South San Francisco-based Onyx Pharmaceuticals last year for $10.4 billion, it expected great things from Onyx’s…

[[Click headline to continue reading.]]

Otonomy Hears Wall Street Ovation as Some Life Sciences IPOs Dim

August 13, 2014 – 4:23 pm

Auris Medical, the Swiss biotech focused on diseases and disorders of the ear, got the catchy ticker symbol (NASDAQ: EARS) when it went public last week. But San Diego’s Otonomy (NASDAQ: OTIC)…

[[Click headline to continue reading.]]